quote:Originally posted by bksundar: Thanks Evergreen You are the man.... Like clockwork, it touches you resistance points and retraces a bit before the next move...
posted
What do expect when a stock rises from 0.000s to 0.0033 ?? It is like a stock going from 1 to 33 in a few days.. It will retrace to the 20s. Even high teens for a healthy move later....
IP: Logged |
posted
One order for $250,000 is not bad. I am sure they are working on more like that or even better. If we are able to break the .0033 barrier, this one will get to at least .007 IMO. It might not require more news to get there. If we get more news like the last, then we might see penny land. I am speculating that today was a profit taking day. I will take the modest gain, though. Just got in this one yesterday at .0015. I am learning to stay away from the.0001 and .0002 stocks and pay a little more when the stock gets above .001 (pay a little more and catch it on its way up) We'll see.
-------------------- It is what it is
IP: Logged |
posted
I am not running scared and selling right now. The lull in activity may just be very short term. This should still run on the recent news and outstanding potential this company has. I am guessing there are more opportunities for sales in England as well as in other countries.
-------------------- It is what it is
IP: Logged |
posted
Many investors got in between 0.0007 and 0.0014, and they wanted to lock in the profits for the weekend. I am planning to add more before closing. I expect more PRs and contracts shortly after the new year. PMED has a history of good runs at this time of the year, especially after she hits the bottom. Good luck.
* We have become more globally oriented with our U.S. and international regulatory-approved products. And we have already established foot prints in the fastest-growing regions of the world, namely Asia and East Europe. A major part of this success has been the establishment of partnerships with leading developers and producers of ultrasound devices like China’s MEDA Co. Ltd., and new-generation software with innovative companies like Reliacon Global (San Ramon, CA).
* We have strengthened the Company’s financial structure with the completion of several fundings, completed in 2005 and 2006, that have allowed us to upgrade our facilities and further advance our research and development programs.
* Specifically, the Company will be entering a fast-track path in revenue and margin growth. By the end of 2008, our goal is to be at an annualized revenue run-rate of $4 million. We believe gross profit margin will be at least 50% (likely higher), which would result in gross profit of $2 million.
* More importantly, our goal is to be slightly cash flow positive by the end of 2008. Again, this will reflect a dramatic improvement from our recent year “negative” cash flows. We view our cash flow performance as one of the true benchmarks of determining the success of our corporate goals.
* During the next 24 months the Company’s goal is to reach annualized sales of $5 million, and gross profit of $2.75 million. Management is committed to maintaining an indirect expense level of $2.5 million during that timeframe. At such performance levels, Paradigm Medical would generate a modest profit from operations and achieve consistently positive cash flow.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Wink]](wink.gif)
![[Big Grin]](biggrin.gif)
